SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-004896
Filing Date
2017-05-09
Accepted
2017-05-09 09:21:19
Documents
62
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 318698
2 ex31-1.htm EX-31.1 19902
3 ex31-2.htm EX-31.2 20004
4 ex32-1.htm EX-32.1 7306
5 ex32-2.htm EX-32.2 7527
  Complete submission text file 0001493152-17-004896.txt   2716207

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE crbp-20170331.xml EX-101.INS 368024
7 XBRL SCHEMA FILE crbp-20170331.xsd EX-101.SCH 39827
8 XBRL CALCULATION FILE crbp-20170331_cal.xml EX-101.CAL 56493
9 XBRL DEFINITION FILE crbp-20170331_def.xml EX-101.DEF 136052
10 XBRL LABEL FILE crbp-20170331_lab.xml EX-101.LAB 293347
11 XBRL PRESENTATION FILE crbp-20170331_pre.xml EX-101.PRE 222545
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 17824849
SIC: 2834 Pharmaceutical Preparations